These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

810 related items for PubMed ID: 17616556

  • 1. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M.
    Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
    Dougados M, Béhier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, Zeidler H, Herman H.
    Arthritis Rheum; 2001 Jan; 44(1):180-5. PubMed ID: 11212158
    [Abstract] [Full Text] [Related]

  • 3. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.
    Barkhuizen A, Steinfeld S, Robbins J, West C, Coombs J, Zwillich S.
    J Rheumatol; 2006 Sep; 33(9):1805-12. PubMed ID: 16960941
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators.
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population.
    Nadarajah A, Abrahan L, Lau FL, Hwang LJ, Fakir-Bolte C.
    Singapore Med J; 2006 Jun; 47(6):534-42. PubMed ID: 16752024
    [Abstract] [Full Text] [Related]

  • 6. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S, Robbins J, West CR, Nemeth MA.
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [Abstract] [Full Text] [Related]

  • 7. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.
    Dahlberg LE, Holme I, Høye K, Ringertz B.
    Scand J Rheumatol; 2009 Jun; 38(2):133-43. PubMed ID: 19165648
    [Abstract] [Full Text] [Related]

  • 8. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
    Pavelka K, Recker DP, Verburg KM.
    Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937
    [Abstract] [Full Text] [Related]

  • 9. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.
    van Denderen JC, van der Paardt M, Nurmohamed MT, de Ryck YM, Dijkmans BA, van der Horst-Bruinsma IE.
    Ann Rheum Dis; 2005 Dec; 64(12):1761-4. PubMed ID: 15901634
    [Abstract] [Full Text] [Related]

  • 10. A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.
    Reuben SS, Buvenandran A, Katz B, Kroin JS.
    Anesth Analg; 2008 Apr; 106(4):1258-64, table of contents. PubMed ID: 18349203
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of celecoxib in treating symptoms of viral pharyngitis: a double-blind, randomized study of celecoxib versus diclofenac.
    Weckx LL, Ruiz JE, Duperly J, Mendizabal GA, Rausis MB, Piltcher SL, Saffer M, Matsuyama C, Levy S, Fort JG.
    J Int Med Res; 2002 Apr; 30(2):185-94. PubMed ID: 12025527
    [Abstract] [Full Text] [Related]

  • 12. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG, Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators.
    Arch Intern Med; 2005 Jan 24; 165(2):161-8. PubMed ID: 15668361
    [Abstract] [Full Text] [Related]

  • 13. Clinical trial: the impact of cyclooxygenase inhibitors on gastrointestinal recovery after major surgery - a randomized double blind controlled trial of celecoxib or diclofenac vs. placebo.
    Wattchow DA, De Fontgalland D, Bampton PA, Leach PL, McLaughlin K, Costa M.
    Aliment Pharmacol Ther; 2009 Nov 15; 30(10):987-98. PubMed ID: 19694636
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial.
    Kellner HL, Li C, Essex MN.
    Curr Med Res Opin; 2012 Sep 15; 28(9):1537-45. PubMed ID: 22852870
    [Abstract] [Full Text] [Related]

  • 15. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen.
    Ta LE, Dionne RA.
    Pain; 2004 Sep 15; 111(1-2):13-21. PubMed ID: 15327804
    [Abstract] [Full Text] [Related]

  • 16. Comparative efficacy and tolerability of two sustained-release formulations of diclofenac: results of a double-blind, randomised study in patients with osteoarthritis and a reappraisal of diclofenac's use in this patient population.
    Wagenitz A, Mueller EA, Frentzel A, Cambon N.
    Curr Med Res Opin; 2007 Aug 15; 23(8):1957-66. PubMed ID: 17631698
    [Abstract] [Full Text] [Related]

  • 17. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
    White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, Weiner E, Verburg KM.
    Am J Cardiol; 2007 Jan 01; 99(1):91-8. PubMed ID: 17196469
    [Abstract] [Full Text] [Related]

  • 18. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.
    Braun J, McHugh N, Singh A, Wajdula JS, Sato R.
    Rheumatology (Oxford); 2007 Jun 01; 46(6):999-1004. PubMed ID: 17389658
    [Abstract] [Full Text] [Related]

  • 19. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL, Cryer B, Amer F, Hunt B.
    Clin Gastroenterol Hepatol; 2007 Oct 01; 5(10):1167-74. PubMed ID: 17916545
    [Abstract] [Full Text] [Related]

  • 20. Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
    van der Heijde D, Da Silva JC, Dougados M, Geher P, van der Horst-Bruinsma I, Juanola X, Olivieri I, Raeman F, Settas L, Sieper J, Szechinski J, Walker D, Boussuge MP, Wajdula JS, Paolozzi L, Fatenejad S, Etanercept Study 314 Investigators.
    Ann Rheum Dis; 2006 Dec 01; 65(12):1572-7. PubMed ID: 16968715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.